SML3627

JWH-133

≥98% (HPLC), CB2 agonist, powder

• Synonym(e): (6AR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene, (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran, 3-(1’,1’-dimethylbutyl)-1-deoxy-Δ8-THC
• Empirische Formel (Hill-System): C₂₂H₃₂O
• CAS-Nummer: 259869-55-1
• Molekulargewicht: 312.49
• UNSPSC Code: 12352200
• NACRES: NA.77
• MDL number: MFCD06795847
• Assay: ≥98% (HPLC)
• Form: powder
• Storage condition: desiccated

Eigenschaften

• Produktname: JWH-133, ≥98% (HPLC)
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• storage condition: desiccated
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear (Warmed)
• storage temp.: -10 to -25°C
• SMILES string: [H][C@@]1(CC(C)=CC2)[C@@]2(C(C)(OC3=C1C=CC(C(C)(CCC)C)=C3)C)[H]
• InChI: 1S/C22H32O/c1-7-12-21(3,4)16-9-10-17-18-13-15(2)8-11-19(18)22(5,6)23-20(17)14-16/h8-10,14,18-19H,7,11-13H2,1-6H3/t18-,19+/m0/s1
• InChI key: YSBFLLZNALVODA-RBUKOAKNSA-N

Beschreibung

Biochem/physiol Actions

JWH-133 is a potent and selective CB2 cannabinoid receptor agonist that suppresses inflammation in experimental colitis and pancreatitis in mice. JWH-133 appears to prevent neuroinflammation, Aβ accumulation, and impairment of cognitive function in transgenic AD models.

Selective CB2 cannabinoid receptor agonist

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable